NINGBO INNO PHARMCHEM CO.,LTD. is committed to advancing women's reproductive health through the provision of high-quality pharmaceutical ingredients. One such critical component is Ulipristal Acetate, a medication that has significantly impacted the field of emergency contraception. This article aims to provide healthcare providers with a comprehensive understanding of Ulipristal Acetate, covering its pharmacological properties, clinical applications, and patient management considerations.

Mechanism of Action and Efficacy: Ulipristal Acetate (UPA), identified by CAS number 126784-99-4, is a selective progesterone receptor modulator (SPRM). Its primary mechanism of action in emergency contraception involves the delay or inhibition of ovulation. This is particularly crucial if administered after the luteinizing hormone (LH) surge has begun, effectively preventing the release of an egg. Studies comparing UPA to levonorgestrel (LNG), another common emergency contraceptive, indicate that UPA can be more effective, especially when administered later within the 120-hour window. The ulipristal acetate effectiveness is a key factor in its widespread recommendation.

Dosage and Administration: The standard ulipristal acetate dosage for emergency contraception is a single 30mg tablet. It is recommended to take this tablet as soon as possible within five days (120 hours) of unprotected sexual intercourse or contraceptive failure. Prompt administration is crucial for maximizing its effectiveness. Patients should be advised against using other hormonal contraceptives for at least five days after taking UPA and to use a barrier method during this period. The ulipristal acetate price can vary, but its efficacy often justifies the investment in women's health.

Safety Profile and Side Effects: While generally well-tolerated, like all medications, UPA can have side effects. Common adverse effects include headache, nausea, abdominal pain, and menstrual irregularities such as spotting or changes in cycle length. The ulipristal acetate side effects are typically mild and transient. However, it is essential for healthcare providers to counsel patients on potential interactions with other medications, such as certain anticonvulsants and St. John's wort, which can reduce UPA's efficacy. The role of a ulipristal acetate manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. is to ensure the purity and consistency of this vital ingredient.

Comparison with Levonorgestrel: A significant aspect for healthcare providers is understanding the differences between UPA and LNG. UPA's extended efficacy window (up to 120 hours) and its demonstrated effectiveness in overweight individuals make it a preferred choice in certain scenarios. The ulipristal acetate vs levonorgestrel debate often centers on these factors, alongside potential differences in side effect profiles. NINGBO INNO PHARMCHEM CO.,LTD. supports healthcare professionals in making informed decisions by providing reliable information on these pharmaceutical intermediates.

Procurement and Supply: For healthcare institutions and pharmaceutical companies seeking a reliable ulipristal acetate supplier, NINGBO INNO PHARMCHEM CO.,LTD. offers a consistent and high-quality source. Understanding the ulipristal acetate manufacturer landscape is crucial for maintaining an uninterrupted supply chain for this essential medication.

In conclusion, Ulipristal Acetate represents a significant advancement in emergency contraception. Its efficacy, safety profile, and broad application window make it an indispensable tool in reproductive healthcare. NINGBO INNO PHARMCHEM CO.,LTD. is proud to contribute to global health by supplying this critical pharmaceutical ingredient.